Perampanel for adjunctive treatment of partial-onset seizures: A pooled dose-response analysis of phase III studies

Perampanel: expanding therapeutic options for patients with medically refractory secondary generalized convulsive seizures

(2013) D. Ko et al.   ACTA NEUROLOGICA SCANDINAVICA

Efficacy and safety of adjunctive perampanel for the treatment of refractory partial seizures: A pooled analysis of three phase III studies

(2013) Bernhard J. Steinhoff et al.   EPILEPSIA

Concentration-effect relationships with perampanel in patients with pharmacoresistant partial-onset seizures

(2013) Barry E. Gidal et al.   EPILEPSIA

Evaluation of adjunctive perampanel in patients with refractory partial-onset seizures: Results of randomized global phase III study 305

(2012) Jacqueline A. French et al.   EPILEPSIA

Perampanel, a selective, noncompetitive α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist, as adjunctive therapy for refractory partial-onset seizures: Interim results from phase III, extension study 307

(2012) Gregory L. Krauss et al.   EPILEPSIA

Perampanel, a Selective, Non-Competitive AMPA Receptor Antagonist as Adjunctive Therapy in Patients with Refractory Partial-Onset Seizures: A Dose Response Analysis from Phase III Studies (P06.117)

(2012) L. Kramer et al.   NEUROLOGY

Adjunctive perampanel for refractory partial-onset seizures: Randomized phase III study 304

(2012) J. A. French et al.   NEUROLOGY

Randomized phase III study 306: Adjunctive perampanel for refractory partial-onset seizures

(2012) G. L. Krauss et al.   NEUROLOGY

Tolerability and safety of perampanel: two randomized dose-escalation studies

(2011) G. L. Krauss et al.   ACTA NEUROLOGICA SCANDINAVICA

Revisiting AMPA Receptors as an Antiepileptic Drug Target

(2011) Michael A. Rogawski   Epilepsy Currents